MedCap AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was SEK 788.5 million compared to SEK 658.4 million a year ago. Revenue was SEK 816 million compared to SEK 676.1 million a year ago. Net income was SEK 77.3 million compared to SEK 55.9 million a year ago. Basic earnings per share was SEK 5.2 compared to SEK 3.8 a year ago. Diluted earnings per share was SEK 5.2 compared to SEK 3.8 a year ago.